Intellia Therapeutics Inc sell StockNews.com
Start price
27.12.25
/
50%
€7.90
Target price
27.12.26
-
Performance (%)
17.94%
Price
19:05
€9.32
Summary
This prediction is currently active. The SELL prediction by StockNews_com currently has a performance of 17.94%. This prediction currently runs until 27.12.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -1.332% | -1.332% |
| iShares Core DAX® | 3.901% | 2.667% |
| iShares Nasdaq 100 | -2.603% | -7.934% |
| iShares Nikkei 225® | -0.545% | -9.754% |
| iShares S&P 500 | -0.881% | -1.488% |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.60
18.01.26
18.01.26
-
18.01.27
18.01.27
-12.08%
19:05
19:05
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.51
11.05.24
11.05.24
-
11.05.25
11.05.25
-67.08%
12.05.25
12.05.25